<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04277572</url>
  </required_header>
  <id_info>
    <org_study_id>17200395</org_study_id>
    <nct_id>NCT04277572</nct_id>
  </id_info>
  <brief_title>Outcomes of Surgery of Aortic Valve</brief_title>
  <acronym>Aortic Surgery</acronym>
  <official_title>Outcomes of Different Modalities for Surgery of Aortic Valve</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Overall Goal: To study the outcomes of patients undergoing aortic valve surgeries, different&#xD;
      approaches such as standard aortic valve replacement, aortic valve repair, novel techniques&#xD;
      as Ozaki's procedure and their subsequent results and complications.&#xD;
&#xD;
        -  Objective 1: Identify predictors of complications following different types of aortic&#xD;
           valve surgery accordingly.&#xD;
&#xD;
        -  Objective 2: Determine the value of each type in terms of advantages and disadvantages.&#xD;
&#xD;
        -  Objective3: Assess outcomes such as postoperative life expectancy, hospital stay,&#xD;
           prognosis and quality of life.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Outcomes of different techniques of aortic valve surgery in the indicated patients for each type of surgery such as :</measure>
    <time_frame>Up to one week</time_frame>
    <description>Number of days of postoperative hospital stay.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Aortic Valve Disease</condition>
  <arm_group>
    <arm_group_label>Aortic valve replacement</arm_group_label>
    <description>using different ways of aortic valve replacement either by prosthetic valves or by ozaki technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Aortic valve replacement</intervention_name>
    <description>Aortic valve surgery</description>
    <arm_group_label>Aortic valve replacement</arm_group_label>
    <other_name>Ozaki procedure</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients registered in cardiac surgery department database, and who meet the listed&#xD;
        inclusion and exclusion criteria will be eligible for the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with severe symptomatic aortic valve lesion.&#xD;
&#xD;
          2. Asymptomatic aortic insufficiency patients with left ventricular dysfunction or&#xD;
             significant left ventricular dilatation (LV end diastolic diameter&gt;70 mm or LV end&#xD;
             systolic diameter&gt;50 mm.&#xD;
&#xD;
          3. Patients with aortic regurgitation caused by:&#xD;
&#xD;
               -  a dilated aortic annulus&#xD;
&#xD;
               -  conjoined cusp prolapse in bicuspid aortic valves (BAV)&#xD;
&#xD;
               -  single cusp prolapse in tricuspid aortic valves&#xD;
&#xD;
               -  aortic valve cusp perforation from endocarditis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with previous aortic root or valve surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 17, 2020</study_first_submitted>
  <study_first_submitted_qc>February 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2020</study_first_posted>
  <last_update_submitted>February 19, 2020</last_update_submitted>
  <last_update_submitted_qc>February 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Gamal Thabet Ahmed</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

